Buckeridge C, Tsamandouras N, Carvajal-Gonzalez S, Brown LS, et al. Once-daily oral small-molecule glucagon-like peptide-1 receptor agonist lotiglipron (PF-07081532) for type 2 diabetes and obesity: Two randomized, placebo-controlled, multiple-ascending-dose Phase 1 studies. Diabetes Obes Metab 2024 May 16. doi: 10.1111/dom.15643.
PMID: 38751362